Logo image of NAKA

KINDLY MD INC (NAKA) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:NAKA - US49457M1062 - Common Stock

0.428 USD
-0.02 (-4.04%)
Last: 1/9/2026, 8:09:01 PM
0.4348 USD
+0.01 (+1.59%)
After Hours: 1/9/2026, 8:09:01 PM
Fundamental Rating

3

Taking everything into account, NAKA scores 3 out of 10 in our fundamental rating. NAKA was compared to 101 industry peers in the Health Care Providers & Services industry. While NAKA seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, NAKA is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

NAKA had negative earnings in the past year.
In the past year NAKA has reported a negative cash flow from operations.
NAKA Yearly Net Income VS EBIT VS OCF VS FCFNAKA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -1M -2M -3M

1.2 Ratios

NAKA has a worse Return On Assets (-13.07%) than 76.24% of its industry peers.
Looking at the Return On Equity, with a value of -18.95%, NAKA is doing worse than 63.37% of the companies in the same industry.
Industry RankSector Rank
ROA -13.07%
ROE -18.95%
ROIC N/A
ROA(3y)-171.26%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NAKA Yearly ROA, ROE, ROICNAKA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 500 -500 1K

1.3 Margins

NAKA's Gross Margin of 98.85% is amongst the best of the industry. NAKA outperforms 100.00% of its industry peers.
NAKA's Gross Margin has been stable in the last couple of years.
NAKA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 98.85%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.15%
GM growth 5YN/A
NAKA Yearly Profit, Operating, Gross MarginsNAKA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 50 -50 -100

More info and screens

4

2. Health

2.1 Basic Checks

NAKA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NAKA has more shares outstanding
NAKA has a better debt/assets ratio than last year.
NAKA Yearly Shares OutstandingNAKA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M
NAKA Yearly Total Debt VS Total AssetsNAKA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1M 2M 3M

2.2 Solvency

Based on the Altman-Z score of -0.04, we must say that NAKA is in the distress zone and has some risk of bankruptcy.
NAKA has a Altman-Z score of -0.04. This is in the lower half of the industry: NAKA underperforms 79.21% of its industry peers.
NAKA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.04
ROIC/WACCN/A
WACC8.98%
NAKA Yearly LT Debt VS Equity VS FCFNAKA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M -2M

2.3 Liquidity

NAKA has a Current Ratio of 0.13. This is a bad value and indicates that NAKA is not financially healthy enough and could expect problems in meeting its short term obligations.
NAKA has a Current ratio of 0.13. This is amonst the worse of the industry: NAKA underperforms 94.06% of its industry peers.
A Quick Ratio of 0.13 indicates that NAKA may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.13, NAKA is doing worse than 94.06% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.13
Quick Ratio 0.13
NAKA Yearly Current Assets VS Current LiabilitesNAKA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

5

3. Growth

3.1 Past

NAKA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -103.31%.
NAKA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -31.13%.
NAKA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.79% yearly.
EPS 1Y (TTM)-103.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-148.3%
Revenue 1Y (TTM)-31.13%
Revenue growth 3Y2.79%
Revenue growth 5YN/A
Sales Q2Q%-40.08%

3.2 Future

Based on estimates for the next years, NAKA will show a very strong growth in Earnings Per Share. The EPS will grow by 25.35% on average per year.
Based on estimates for the next years, NAKA will show a very strong growth in Revenue. The Revenue will grow by 215.68% on average per year.
EPS Next Y52.12%
EPS Next 2Y41.15%
EPS Next 3Y25.35%
EPS Next 5YN/A
Revenue Next Year-33.16%
Revenue Next 2Y338.3%
Revenue Next 3Y215.68%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NAKA Yearly Revenue VS EstimatesNAKA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M
NAKA Yearly EPS VS EstimatesNAKA Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -0.1 -0.2 -0.3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NAKA. In the last year negative earnings were reported.
Also next year NAKA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NAKA Price Earnings VS Forward Price EarningsNAKA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NAKA Per share dataNAKA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1 -1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as NAKA's earnings are expected to grow with 25.35% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.15%
EPS Next 3Y25.35%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NAKA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

KINDLY MD INC

NASDAQ:NAKA (1/9/2026, 8:09:01 PM)

After market: 0.4348 +0.01 (+1.59%)

0.428

-0.02 (-4.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-19 2025-11-19/amc
Earnings (Next)03-26 2026-03-26
Inst Owners24.99%
Inst Owner ChangeN/A
Ins Owners6.28%
Ins Owner Change81.52%
Market Cap188.26M
Revenue(TTM)1.98M
Net Income(TTM)-90.49M
Analysts82.5
Price Target1.27 (196.73%)
Short Float %5.13%
Short Ratio1.1
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-75%
PT rev (3m)-84.37%
EPS NQ rev (1m)0%
EPS NQ rev (3m)50%
EPS NY rev (1m)0%
EPS NY rev (3m)-425%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.5%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.38%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 95.06
P/FCF N/A
P/OCF N/A
P/B 0.39
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.12
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-1.59
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0
BVpS1.09
TBVpS-0.32
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -13.07%
ROE -18.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 98.85%
FCFM N/A
ROA(3y)-171.26%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.15%
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 93921.5%
Cap/Sales 34432.7%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.13
Quick Ratio 0.13
Altman-Z -0.04
F-Score4
WACC8.98%
ROIC/WACCN/A
Cap/Depr(3y)300.3%
Cap/Depr(5y)N/A
Cap/Sales(3y)7.84%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-103.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-148.3%
EPS Next Y52.12%
EPS Next 2Y41.15%
EPS Next 3Y25.35%
EPS Next 5YN/A
Revenue 1Y (TTM)-31.13%
Revenue growth 3Y2.79%
Revenue growth 5YN/A
Sales Q2Q%-40.08%
Revenue Next Year-33.16%
Revenue Next 2Y338.3%
Revenue Next 3Y215.68%
Revenue Next 5YN/A
EBIT growth 1Y-465.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-394.94%
EBIT Next 3Y84%
EBIT Next 5YN/A
FCF growth 1Y-649.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-583.85%
OCF growth 3YN/A
OCF growth 5YN/A

KINDLY MD INC / NAKA FAQ

What is the ChartMill fundamental rating of KINDLY MD INC (NAKA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to NAKA.


What is the valuation status for NAKA stock?

ChartMill assigns a valuation rating of 1 / 10 to KINDLY MD INC (NAKA). This can be considered as Overvalued.


How profitable is KINDLY MD INC (NAKA) stock?

KINDLY MD INC (NAKA) has a profitability rating of 1 / 10.